CCB International (Holdings) Limited, established in 1973, is an investment services firm based in Hong Kong and owned by China Construction Bank Corporation. The company operates across a comprehensive value chain that encompasses three primary segments: Pre-IPO, IPO, and Post-IPO services. CCB International offers a wide array of services, including underwriting, financial advisory, corporate mergers and acquisitions, restructuring, and refinancing for listed companies. Additionally, the firm engages in direct investment and asset management, alongside providing securities brokerage, market research, and investment consultancy. Through its subsidiaries, such as CCB International Capital and CCB International Asset Management, the firm delivers diverse investment solutions and services to meet the needs of its clientele.
Xinqiang Technology is a digital full-stack solution provider specializing in integrated solutions that combine hardware, software, cloud services, and artificial intelligence (AI) tailored for traditional industries.
Syngenta
Debt Financing in 2024
Syngenta, headquartered in Basel, Switzerland, is a global leader in agribusiness, dedicated to sustainable agriculture and improving food security. With over 28,000 employees in 90 countries, Syngenta develops and provides a wide range of crop protection products, including insecticides, fungicides, and herbicides, as well as bio-based solutions and genetically modified seeds. These products aim to enhance crop yields, increase resilience to environmental stresses, and minimize the use of natural resources. Syngenta's venture capital arm, Syngenta Group Ventures, established in 2009, invests in agriculture and food technology startups, supporting innovation in the sector. The firm is stage-agnostic, typically investing alongside other financial and corporate venture capital investors, and often takes board or board observer roles to support its portfolio companies.
Galaxy Bot
Venture Round in 2024
Galaxy Bot is an innovative robotics company that provides intelligent universal service robotic products.
Sinogene
Series C in 2024
Sinogene is a company that specializes in pet cloning and cell transfer solutions, utilizing somatic cell nuclear transfer technology. It focuses on the cloning and breeding of various types of pets, including working dogs, pet dogs, and purebred breeds, while also offering services for the preservation of somatic cell genes. The company is committed to advancing animal genetic research and believes that improved breeding practices will benefit this field. Sinogene's team comprises scientists, doctors, and veterinary specialists dedicated to providing reliable and effective pet cloning and gene editing services for pet owners.
Hangzhou Times Electric Technology
Series A in 2023
Times Electric is a developer of new energy vehicles and core components.
Thor Innovation
Series A in 2023
Thor Innovation is a high-tech company that specializes in haptic technology, which simulates tactile sensations electronically. The firm develops and manufactures solutions aimed at enhancing user experiences in consumer electronics, automotive applications, and healthcare. By utilizing wide-band haptic technology, Thor Innovation provides integrated solutions that deliver immersive experiences in extended reality and digital interactions through physical feedback. This technology allows consumers to engage with digital environments in a more realistic manner, enhancing the overall interaction experience.
Chilye
Venture Round in 2022
Chilye specializes in high-power electronic components and high-voltage connectors, focusing on the development and production of power distribution units, manual service disconnectors, charging and swapping connectors, and portable charging equipment. The company is dedicated to creating a comprehensive range of high-voltage electrical units specifically designed for alternative energy vehicles. By emphasizing technical research and development, Chilye provides clients with integrated solutions for complete vehicle systems in the electric vehicle sector.
GalaxySpace
Series D in 2022
GalaxySpace is a satellite manufacturer based in Haidian, China, founded in 2016. The company specializes in developing and building a low Earth orbit (LEO) broadband satellite constellation and a 5G communication network. GalaxySpace offers various satellite applications, including monitoring systems for airports, parking, and oil reserves, as well as land assessment services. Their product range includes communication payloads, phased array antennas, power management systems, solar panels, and core platform components. Additionally, the company provides one-stop artificial intelligence satellite launch services, facilitating convenient communication and information access for clients while reducing network costs.
Origin Quantum
Series B in 2022
Origin Quantum is a full-stack quantum computing company based in China, established in 2017. The company specializes in the development and application of quantum computing technologies, including quantum chips, measurement and control systems, and quantum software. It offers a quantum computing cloud service platform that facilitates access to quantum computing resources beyond laboratory settings. Origin Quantum is committed to advancing the engineering and industrialization of quantum computing in China, aiming to accelerate its applications across various sectors, including quantum artificial intelligence.
TargetRx
Series B in 2022
Shenzhen TargetRx, Inc. is a pharmaceutical research and development company based in Shenzhen, China, established in 2014. As a Sino-American joint venture, it focuses on the creation of innovative anti-tumor drugs, specializing in third-generation small molecule targeted therapies for cancer patients. The company is dedicated to addressing challenges such as acquired drug resistance in cancer treatment. Under the leadership of Dr. Yihan Wang, a prominent medical expert with extensive experience in small molecule targeted therapies, Shenzhen TargetRx aims to position itself as a leading platform for targeted drug development. The company engages in the design, screening, evaluation, optimization, and research of original anti-tumor drug candidates, holding independent intellectual property rights to its innovations. With a commitment to improving cancer treatment outcomes, Shenzhen TargetRx strives to transform cancer from a leading cause of mortality into a manageable chronic condition.
Mirxes
Series C in 2022
Mirxes is a biotechnology company that discovers, develops, and delivers accurate preventive healthcare solutions for cancer, cardiovascular, metabolic and infectious diseases. The company's mission is to make diagnostic solutions for the early detection of diseases accessible on a global scale. It develops and commercializes accurate and non-invasive blood-based miRNA test kit products for the early detection of cancer and other diseases.
Tianbing Technology
Series B in 2022
Tianbing Technology is an advanced aerospace propulsion system supplier and aerospace vehicle provider. Tianbing Technology independently develops the next-generation ambient temperature green HCP liquid propellant and minimalist aerospace propulsion system. As an upgraded product of traditional chemical propulsion system, it can meet cost-effective aerospace. Advance system supporting needs. The next-generation green HCP aerospace propulsion system, first tested by Tianbing Technology, can be used in the small-vehicle main power and launch vehicle upper-level propulsion system.
Keydom
Post in 2022
Keydom is the provider of smart card industry application solution services.
Moore Threads
Series A in 2021
Moore Threads, founded in 2020 and based in Beijing, China, specializes in developing Graphics Processing Unit (GPU) technology and services. The company focuses on enabling visual computing, artificial intelligence, and high-performance computing applications for a diverse range of sectors, including gaming and the creative industry. By providing advanced GPU technology and services for data centers, edge computing servers, professional workstations, and high-performance PCs, Moore Threads helps clients achieve significant computational power for their processes.
Wego
Series A in 2021
Wego is a manufacturer of producing safe and affordable medical equipment.
Hozon
Series D in 2021
Zhejiang Hozon New Energy Automobile Co., Ltd., founded in 2014 and headquartered in Tongxiang, China, specializes in the design and manufacture of electric vehicles. The company produces models such as the Nezha U, Nezha N01, and Eureka 02, focusing on integrating innovative technology through research and development. Hozon emphasizes intelligent manufacturing and multi-channel sales services, aiming to deliver high-quality, cost-effective intelligent electric vehicles. By prioritizing advancements in electricity, intelligence, and connectivity, Hozon seeks to enhance the user experience, providing a simple, intuitive, and comfortable mode of transportation. The company also maintains research and development centers in both China and the United States.
SJ Semi
Series C in 2021
SJ Semi is a MEOL foundry focused on front-end wafer manufacturing and quality systems. The company specializes in bumping, Cu pillar, RDL, and testing services for 12" wafers while investing in R&D for fan-out, TSV, interposer, and 3D technologies. With over a decade of experience, SJ Semi aims to support advancements in the semiconductor market.
IASO Biotherapeutics
Series C in 2021
Nanjing IASO Biotherapeutics is a clinical stage biotechnology company established in 2017 and located in Nanjing, China. The company specializes in the discovery, development, and commercialization of innovative therapies aimed at treating cancer. IASO Biotherapeutics is particularly focused on engineered autologous and allogenic T cell therapies, which are designed to enhance the immune system's capability to identify and eliminate cancer cells. Through its research and development efforts, the company aims to provide effective cancer treatments that leverage the body's own immune response.
Orbusneich Medical
Series B in 2021
OrbusNeich Medical is a global medical device manufacturer based in China, specializing in endovascular interventional instruments. Established in 2001, the company has developed a comprehensive range of vascular solutions that are recognized for their industry-leading standards. As of 2023, OrbusNeich's revenue is predominantly generated from its coronary interventional medical devices, including scoring balloons, non-compliant balloons, and stents, which collectively account for 82.7% of total revenue. Geographically, the company derives the largest share of its revenue from Japan (24.7%), followed by Europe, the Middle East, and Africa (23.6%), with the remainder coming from the Asia-Pacific region and the United States. OrbusNeich continues to focus on innovation and quality in its product offerings to improve patient outcomes in vascular interventions.
Kuaikan Manhua
Series F in 2021
Kuaikan Manhua is an online and mobile platform for original online comic artwork targeting young readers. Founded in 2014, Kuaikan Manhua is a comic-reading platform and community of interest that is popular among users. As of January 2019, the total number of users of the comics app is over 170 million, and the monthly users are over 40 million, and the market share in the comics market is more than half*. Kuaikan World’s vision is to build an ideal ecosystem of cultural-entertainment in the future, as well as bring happiness to the world. Kuaikan aims to help comic creators to create more widely-popular comics with positive, energetic and warm contents to millions of users.
Beijing Health Guard Biotechnology
Private Equity Round in 2021
Beijing Health Guard Biotechnology is a Beijing-based research and development company that focuses on the development of recombinant protein drugs and vaccines. Founded in 2008, the company specializes in creating novel biopharmaceuticals using a structure-guided design approach. Its primary area of expertise lies in the research and industrialization of recombinant protein vaccines, particularly for human papillomavirus (HPV). Beijing Health Guard Biotechnology is advancing multiple innovative candidate vaccines targeting various infectious diseases, with its core products including both trivalent and nonavalent HPV vaccines.
SVOLT
Series B in 2021
SVOLT manufacturer of electric batteries. They specialize in the manufacturing of automotive power batteries and energy storage systems. Their market applications include passenger cars, commercial vehicles, energy storage, and light power solutions. Their products include batteries and energy storage batterie. They provide users with energy vehicle charging piles, batteries recycling, and solutions.
Beijing Gene+ Technology
Series C in 2021
Beijing Gene+ Technology, founded in 2015 and based in Beijing, China, specializes in gene testing services aimed at cancer prevention and early detection. The company provides a range of offerings, including clinical testing, medical device manufacturing, and scientific cooperation services. It plays a significant role in supporting precision medicine by delivering critical data for treatment planning. Beijing Gene+ Technology operates in approximately 100 hospitals and has served thousands of cancer patients across China, contributing to advancements in personalized healthcare solutions.
Geneplus-Beijing
Series C in 2021
Geneplus Co.,Ltd. is a market leader in biotechnology and molecular diagnostic distribution. The company is primarily concerned with molecular biological solutions for Applied Life Science and Molecular Diagnostics.
Shanghai Cell Therapy Group
Series D in 2021
Shanghai Cell Therapy Group Co., Ltd., founded in 2013 and headquartered in Shanghai, China, specializes in the field of cell therapy technology. The company offers a range of services, including technical consulting, technology transfer, and investment in the healthcare sector. It operates a cellular diagnosis center that integrates cellular research and treatment services, focusing on tumor immune cell therapy treatments. Additionally, the company provides cellular cold storage, develops cellular pharmaceuticals, and conducts antibody research, thereby enabling patients to undergo genetic testing and supplying valuable research data to cancer facilities.
Didi Woya
Series A in 2021
Didi Woya is a pioneering startup focused on creating autonomous vehicles for rideshares. Their goal is to revolutionize transportation services by providing efficient, affordable, and comfortable rides with rapid response times and budget-friendly fares. Utilizing cutting-edge technologies such as machine learning, the Internet of Things, and comprehensive 360-degree monitoring, DiDi Woya is dedicated to developing and commercializing innovative solutions in the field.
Youyun
Debt Financing in 2020
Youyun is the designer of a full-stack operation and maintenance service platform aimed at increasing company efficiency. They specialize in creating a variety of cloud-based business software solutions that increase the effectiveness of enterprise management and maintenance while enabling quick and efficient digital transportation for a range of sectors.
Biostar Technologies
Series E in 2020
Beijing Biostar Technologies, Ltd., established in 2002, is a Chinese biopharmaceutical company based in Beijing. It specializes in the development of anti-tumor chemotherapy biopharmaceutical molecules, with a focus on creating innovative small molecule chemical drugs for cancer treatment. The company, led by a team of Chinese scientists previously based in the United States, including Dr. Tang Li and Dr. Qiu Rongguo, aims to advance its technology to an international level.
UtmoLight
Seed Round in 2020
UtmoLight is engaged in the research, development, and manufacturing of perovskite-based photovoltaic and optoelectronic products. The company focuses on creating advanced perovskite solar cells and modules, along with perovskite quantum dots and associated precursor materials. It specializes in synthesizing full visible spectrum perovskite quantum dots and developing enhanced filter films utilizing these quantum dots. By leveraging its expertise in perovskite technology, UtmoLight aims to provide high-quality photoelectric products for clients in the photovoltaic and optoelectronic sectors.
Hinova Pharma
Series C in 2020
Hinova Pharma is an innovative drug research and development manufacturer that provides users with compound HC-1119 androgen receptor (AR) antagonism by using drug discovery systems such as medicinal chemistry, biological screening, process research, quality research, clinical reporting, and clinical research. Drugs, HC-1102 androgen receptor inhibitors and other products, for the treatment of advanced prostate cancer and breast cancer.
Sinovent
Series C in 2020
Sinovent Inc., established in 2016, is a global biopharmaceutical company with headquarters in Suzhou, China, and additional offices in Beijing, China, and Boston, U.S.A. The company specializes in developing advanced treatments for global healthcare challenges, with a focus on oncology, autoimmune diseases, and infectious diseases. Sinovent's portfolio comprises 12 products in development, leveraging its expertise in science, management, and finance, and commitment to global standard excellence through its advanced biotechnology platform.
Thousand Oaks Biopharmaceuticals
Series B in 2020
Thousand Oaks Biopharmaceuticals, Inc., established in 2017 and headquartered in Haimen, China, specializes in contract development and manufacturing services for the biotechnology industry. The company focuses on developing technologies to produce protein and vaccine compounds, offering integrated control solutions that optimize processes, increase protein expression, and reduce production scale. Thousand Oaks provides personalized, chemically defined cell culture media, formula production, technical support, and ancillary services to its clients in the biopharmaceutical sector.
TargetRx
Series A in 2020
Shenzhen TargetRx, Inc. is a pharmaceutical research and development company based in Shenzhen, China, established in 2014. As a Sino-American joint venture, it focuses on the creation of innovative anti-tumor drugs, specializing in third-generation small molecule targeted therapies for cancer patients. The company is dedicated to addressing challenges such as acquired drug resistance in cancer treatment. Under the leadership of Dr. Yihan Wang, a prominent medical expert with extensive experience in small molecule targeted therapies, Shenzhen TargetRx aims to position itself as a leading platform for targeted drug development. The company engages in the design, screening, evaluation, optimization, and research of original anti-tumor drug candidates, holding independent intellectual property rights to its innovations. With a commitment to improving cancer treatment outcomes, Shenzhen TargetRx strives to transform cancer from a leading cause of mortality into a manageable chronic condition.
Intellifusion
Series C in 2020
Shenzhen Intellifusion Technologies Co., Ltd. is a technology company founded in August 2014, specializing in artificial intelligence and chip technology. The company focuses on developing core products, including algorithm software and chips, aimed at structuring the physical world through AI to create digital twin cities. Intellifusion's comprehensive AI technology platform supports various applications in public safety, social governance, new business, and AIoT. Its innovative solutions have been implemented across numerous cities in China, including Shenzhen, Beijing, and Shanghai, as well as in Southeast Asia and over 100 other regions. Intellifusion is backed by a team of international experts dedicated to advancing AI technology for diverse societal needs.
Immunocore
Series B in 2020
Immunocore Limited is a biotechnology company based in Abingdon, United Kingdom, with a focus on discovering and developing novel therapeutics for cancer, viral diseases, and autoimmune conditions. The company specializes in T cell receptor (TCR) technology, which allows it to create innovative bispecific immunotherapies. Its lead product candidate, IMCgp100, is currently undergoing clinical trials for the treatment of metastatic melanoma. Immunocore's proprietary platform enables efficient manufacturing of TCR-based drugs, addressing significant unmet medical needs. Founded in 1999 and previously known as Avidex Limited, Immunocore has expanded its operations with an additional office in Conshohocken.
Suzhou Kintor Pharmaceuticals
Series D in 2019
Suzhou Kintor Pharmaceuticals is a biopharmaceutical company established in 2009, primarily engaged in the research and development of innovative drugs targeting various cancers and androgen receptor-related diseases. Headquartered in Suzhou, China, the company focuses on addressing significant unmet medical needs in conditions such as metastatic castration-resistant prostate cancer, breast cancer, and liver cancer, which collectively represent a substantial portion of the global cancer burden. Kintor's leading drug candidates include Proxalutamide, currently undergoing clinical trials for prostate and breast cancer, and Pyrilutamide, which targets androgenetic alopecia and acne vulgaris. The company also develops several other drug candidates, including ALK-1 for liver cancer and Detorsertib, a second-generation mTOR inhibitor for metastatic solid tumors. Kintor's extensive product pipeline is built on proprietary research and development, aiming to deliver both “best-in-class” and “first-in-class” therapeutic options to patients in need.
Chengjia Apartment
Series A in 2019
Chengjia Apartment is a rental start-up that provides different product choices for apartments, hotels, and homestays. Chengjia Apartment extends the business scope to weekly rent, monthly rent, and long-term rent. The company creates a high-quality living environment with ingenuity, take care of every guest with hotel-style service, and creates a warm, comfortable, and temperature-friendly home. Chengjia Apartment is jointly established by China Living Hotel Group and IDG Capital. It has laid out nearly 100 properties in first-tier cities nationwide, with more than 10,000 houses and services. It was founded on 2015 and is headquartered in Shanghai, China.
Boston Micro Fabrication
Series A in 2019
Boston Micro Fabrication is a micro-scale 3D printing system manufacturer dedicated to the development of micro-scale 3D printing systems and functional composites. used in microfluidics, medical devices, electronics, and education.
Vapo Health
Series A in 2019
Vapo Health is a medical device company based in Kunshan City, China, focused on developing, manufacturing, and distributing products for respiratory system health. Established in 2015, the company employs advanced nano-scale atomized micro-hole technology to enhance drug delivery and particle efficiency in its offerings. Its product range includes nebulizers, spacers, thermometers, intelligent breathing trainers, and aerosol devices, as well as OEM and ODM services. Vapo Health aims to provide innovative and effective solutions to support respiratory health recovery and improve patient outcomes.
Inspur Cloud
Series B in 2019
Inspur Cloud, established in 2010 with headquarters in Jinan, China, specializes in providing global datacenter and cloud computing solutions. It offers a range of hardware including servers and storage systems, along with software solutions such as artificial intelligence and high-performance computing platforms. Inspur Cloud caters to diverse clients, including governments, enterprises, and industries, aiming to enhance their transparency and efficiency through secure digital transformation.
Emirates National Oil Company
Debt Financing in 2019
Emirates National Oil Company (ENOC), established in 1993 and wholly owned by the Dubai Government, plays a pivotal role in the economic diversification and sustainable development of the United Arab Emirates. Based in Dubai, ENOC focuses on both upstream and downstream activities in the oil and gas sector. Over the years, the company has diversified its operations, expanding into various high-growth sectors to generate long-term value for its stakeholders while providing oil and gas services to clients worldwide.
Momenta
Series C in 2018
Momenta is an autonomous driving startup operating out of Beijing. Its deep-learning-based software in perception, HD semantic mapping, and data-driven path planning enables the realization of full autonomy. Momenta offer multi-level autonomous driving solutions as well as big data products and services. Momenta’s team is composed of experts in computer vision and deep learning, including one of the authors of Faster R-CNN and ResNet, the most popular deep learning network, as well as winners of ImageNet 2015, MS COCO Challenge 2015, and ImageNet 2017. The company is leading the autonomous driving software space with advanced technical competence and a strong commitment to innovation.
Pengyang Medical
Series A in 2018
Pengyang Medical specializes in medical monitoring hardware and information products, particularly in the realm of electrocardiogram (ECG) artificial intelligence. The company is dedicated to the research, development, and promotion of advanced ECG technology aimed at enhancing cardiovascular diagnostic services. By integrating medical resources and cutting-edge technologies, Pengyang Medical provides detailed information about patients' cardiovascular health, enabling healthcare practitioners to improve diagnostic accuracy and reduce the risk of misdiagnosis.
Suning.com
Series A in 2018
Suning.com is a prominent Chinese online shopping platform that offers a wide range of products, including clothing, snacks, electronics, and appliances. The company emphasizes a comprehensive retail experience by integrating smart retail solutions with full category operations and omni-channel services, enabling customers to shop seamlessly through physical stores, mobile devices, PCs, and TVs. Additionally, Suning.com leverages logistics and global expansion strategies to enhance its service offerings. Founded in 1990, Suning Holdings Group, which includes Suning.com, has established itself as a leading commercial enterprise in China, recognized for its significant annual revenue and diverse business interests across various sectors, including logistics, financial services, and media. Suning's commitment to improving the quality of life through technological advancements and innovative retail solutions underscores its influence in the retail landscape.
Ascentage Pharma
Series C in 2018
Ascentage Pharma Group International is a clinical-stage biotechnology company focused on developing novel small-molecule therapies for cancer, hepatitis B virus (HBV), and age-related diseases. Founded in 2009 and headquartered in Suzhou, China, the company has established a diverse pipeline of drug candidates, including HQP1351, a BCR-ABL/KIT inhibitor targeting resistant mutations, and APG-2575, an orally administered Bcl-2 selective inhibitor for hematologic malignancies. Additional candidates include APG-1252, aimed at restoring apoptosis in various solid tumors, and APG-115, which targets the MDM2-p53 interaction in solid tumors and lymphoma. Ascentage Pharma also develops APG-1387 for advanced solid tumors and chronic HBV infection, alongside other therapies for non-small-cell lung carcinoma and chronic lymphocytic leukemia. The company has entered into clinical collaborations to explore innovative treatment combinations, furthering its commitment to addressing challenging diseases in the oncology landscape.
Blocksteam
Series A in 2018
Blocksteam is a Gaming company.
LLVision
Series B in 2018
LLVISION was founded in 2014 by an elite team from Google, Lenovo, Microsoft, Intel, China Aeronautics, Nokia, Broadcom, etc.Their mission is to help the industry leaders intellectualize business processes through the first perspective innovation linked with multi-dimension connections, cognition and synergy and upgraded human-machine collaboration.
8Trip
Series C in 2018
8Trip, a China-based online travel service which connects suppliers with sellers. Currently, 8Trip covers the markets of Wuxi, Nanjing, and Anhui in China, and is planning to enter the Shanghai market next year. The company has partnerships with about 1,000 travel agencies and more than 4,000 service outlets. 8Trip was founded in December 2011 under the company name Octopus Online Tourism Development, with headquarters in Suzhou.
Oxford Nanopore Technologies
Venture Round in 2018
Oxford Nanopore Technologies is a biotechnology company specializing in nanopore-based sequencing technology for analyzing DNA, RNA, proteins, and small molecules. Its diverse product line includes the portable MinION device, the benchtop PromethION, the GridION system, and Flongle, which caters to on-demand sequencing needs. The technology enables real-time data streaming and is applicable across various fields such as human genomics, cancer research, microbiology, plant science, and environmental studies. Additionally, Oxford Nanopore's products support rapid and accessible molecular analysis, making them suitable for both laboratory and field use. The company's innovations are backed by a robust patent portfolio and are utilized in over 80 countries, addressing needs in healthcare, agriculture, and education. Founded in 2005 and headquartered in Oxford, United Kingdom, Oxford Nanopore also maintains offices in several other countries, enhancing its global reach in advancing genomic research and applications.
Innocare
Venture Round in 2018
InnoCare is a biopharmaceutical company based in China, focused on discovering, developing, and commercializing innovative treatments for cancer and autoimmune diseases. The company boasts a skilled scientific team with extensive experience in drug innovation from both the U.S. and China, supported by an accomplished Scientific Advisory Board comprised of experts from prominent universities, hospitals, and the pharmaceutical sector. InnoCare's product pipeline includes several key therapies, such as orelabrutinib, ibrutinib, zanubrutinib, and tafasitamab, targeting hematological tumors, solid tumors, and autoimmune disorders. The company is also dedicated to addressing autoimmune diseases linked to abnormal B-cell or T-cell functions, positioning itself as a leader in advancing medical treatments and tackling complex health challenges.
Chezhency.com
Series B in 2018
Chezhency.com is a B2B auto trading platform based in Shenzhen, China, founded in 2015. The company offers a comprehensive suite of services that includes automotive logistics, supply chain finance, consumer credit, and automobile insurance. By integrating these essential services, Chezhency.com aims to streamline the automotive trading process, providing businesses with efficient solutions that enhance operational effectiveness in the automotive sector.
Suzhou Kintor Pharmaceuticals
Series C in 2018
Suzhou Kintor Pharmaceuticals is a biopharmaceutical company established in 2009, primarily engaged in the research and development of innovative drugs targeting various cancers and androgen receptor-related diseases. Headquartered in Suzhou, China, the company focuses on addressing significant unmet medical needs in conditions such as metastatic castration-resistant prostate cancer, breast cancer, and liver cancer, which collectively represent a substantial portion of the global cancer burden. Kintor's leading drug candidates include Proxalutamide, currently undergoing clinical trials for prostate and breast cancer, and Pyrilutamide, which targets androgenetic alopecia and acne vulgaris. The company also develops several other drug candidates, including ALK-1 for liver cancer and Detorsertib, a second-generation mTOR inhibitor for metastatic solid tumors. Kintor's extensive product pipeline is built on proprietary research and development, aiming to deliver both “best-in-class” and “first-in-class” therapeutic options to patients in need.
ByteDance
Series D in 2017
ByteDance is a technology company that develops and operates a range of content platforms, most notably TikTok and Douyin. It aims to enhance user experiences through innovative technology, allowing individuals to connect, create, and consume content seamlessly. The company specializes in mobile applications that cater to online media, entertainment, and social networking, leveraging artificial intelligence to deliver personalized content that aligns with users' preferences. In addition to its flagship platforms, ByteDance provides tools that facilitate content creation and collaboration, reflecting its commitment to enriching lives through technology.
CooTek
Series D in 2017
CooTek is a global mobile internet company founded in 2008 and headquartered in Shanghai, with additional offices in locations such as Silicon Valley and Beijing. The company specializes in developing innovative mobile applications and artificial intelligence technology, aiming to enhance user expression and content engagement. Its flagship product, TouchPal Keyboard, offers a superior input experience for both Android and iPhone users. CooTek's portfolio includes a variety of content-rich applications across multiple categories, including online literature, mobile games, and scenario-based apps in areas such as fitness and healthcare. The company boasts a substantial user base, with its products achieving an average of 213.7 million monthly active users globally in 2018. CooTek is also committed to technology innovation, holding over 170 patents and operating a big data development center and AI lab in Silicon Valley. Additionally, the company actively contributes to academic discourse in the fields of big data and AI, with research presented at prestigious conferences.
Sooner
Angel Round in 2017
Sooner develops video technology products and services.
MEGVII
Series C in 2016
Incorporated in 2011, Megvii is committed to make greatest value for customers and the whole society with extraordinary technology. Megvii is an Artificial Intelligence company specialized in providing enterprises and developers with intelligent solutions and data services, and is dedicated to the mission of “Create machines that can see and think”. Based on its original deep learning system Brain++, Megvii seeks to build AI Engine, a core fundamental technology powering various AI application. It is leveraging on recognition, control, optimization and other algorithms to connect individuals, objects and scenarios, building a product platform of IoT OS. It is connecting standardized hardware like sensors, robots and personal devices with AI+IoT (AIoT), thus commercializing three application-oriented IoT brains on a large scale, namely, city brain, supply chain brain, and personal life brain. Megvii is building an operation system for the era of AIoT. Megvii is an AIoT solutions expert.
Shouqi Car Rental
Venture Round in 2016
Shouqi Car Rental is a car rental service and a subsidiary of Shouqi Group, a transportation company headquartered in China. It provides both business-to-business and business-to-consumer car rental solutions for institutional and individual customers. The company specializes in offering short-term and long-term rental options, allowing users to access vehicles on-demand by the hour or day. Shouqi Car Rental operates in various locations, including cities and airports within China and internationally, facilitating convenient transportation for its clientele.
Firstp2p
Series C in 2016
Firstp2p is an online lending information platform based in Beijing, China, established in 2013. The company connects individual investors with small and medium enterprises that are unable to secure traditional bank financing. In addition to facilitating these connections, Firstp2p offers a range of financial products, including car loans, mortgages, and financial leasing, aimed at supporting the funding needs of these businesses.
Firefly Games
Venture Round in 2016
Firefly Games Inc. is a mobile game developer and publisher based in Los Angeles, California, with additional offices in Shanghai. Founded in 2014, the company focuses on creating community-driven mid-core and hardcore gaming experiences for iOS and Android platforms. Firefly Games is known for titles such as Tourivia, Battle Hatchers, Fury Fables, and DreamWorks Universe of Legends. The company emphasizes the development of story-based games that are regularly updated to enhance player engagement and community interaction. Additionally, Firefly Games is involved in the fields of virtual reality and e-sports, aiming to connect gamers through evolving gameplay experiences. As of 2020, Firefly Games operates as a subsidiary of Riva Technology and Entertainment Limited and has established a strategic partnership with MSM Corporation International Limited.
Weidong Cloud Education
Venture Round in 2016
Weidong Cloud Education Group is focused on bridging the educational divide between various regions by enhancing education through technology. The company develops an internet-based educational ecosystem that offers a wide range of courses, including basic, vocational, and international education in sectors such as finance, management, medicine, and technology. Utilizing integrated "Cloud + Client" solutions, the company collaborates with leading global enterprises in software and hardware to create a comprehensive public service platform for educational resources. This initiative includes the establishment of a cloud data center and the Weidong International Education Cloud Industrial Park in Qingdao's Blue Silicon Valley, aimed at delivering high-quality educational services worldwide.
Ant Group
Series B in 2016
Ant Group Co., Ltd. is a leading provider of digital payment and financial services in China, known for its flagship product, Alipay, a widely used digital payments platform. Established in 2000 and headquartered in Hangzhou, the company offers a variety of financial solutions, including Yu'e Bao, an online cash management platform that invests users' funds in a money market fund; Huabei, a consumer credit service facilitating buy now, pay later options; and MYbank, an online bank focused on serving small businesses and entrepreneurs. Additionally, Ant Group operates Xiang Hu Bao, a mutual aid platform for health protection, and Zhima Credit, a credit assessment service for businesses. The company aims to foster digital transformation across the service industry, ensuring that consumers and small enterprises have equal access to inclusive and sustainable financial services. In July 2020, it rebranded from Ant Small and Micro Financial Services Group Co., Ltd. to Ant Group Co., Ltd.
Wellong Etown
Venture Round in 2016
Wellong Etown allows the clients to travel by car and ship all over the world, with high income and low cost for finding online smart load. Huilong installs a satellite positioning terminal for you with low fees and good service. The company finds empty trucks for your goods to be transported. It also transports online dispatching calls with high efficiency and punctuality.
Phylion Battery
Series A in 2015
Phylion Battery is a manufacturer based in Suzhou, China, specializing in the development, production, and sales of lithium-ion batteries. Utilizing lithium manganate as its positive electrode material, the company has established an annual production capacity of 5GWh. With over 15 years of experience in technology transformation, Phylion has successfully served 8 million end users and provided battery solutions for more than 45,000 electric vehicles globally. The company is recognized as a high-tech enterprise in the power lithium battery sector and is actively involved in research and development within the energy storage field. Phylion is committed to delivering innovative power supply solutions for new energy vehicles and various industrial applications worldwide.
XYWY.com
Series B in 2015
XYWY.com is an online platform that provides a range of medical services aimed at facilitating patient access to healthcare. The platform enables users to search for medical professionals and offers free consultations, helping patients obtain essential medical information and preliminary diagnoses. In addition to these services, XYWY.com allows clients to register for appointments and assists with drug searches and shopping guidance, consolidating various healthcare needs into a single, user-friendly interface.
Firstp2p
Series A in 2014
Firstp2p is an online lending information platform based in Beijing, China, established in 2013. The company connects individual investors with small and medium enterprises that are unable to secure traditional bank financing. In addition to facilitating these connections, Firstp2p offers a range of financial products, including car loans, mortgages, and financial leasing, aimed at supporting the funding needs of these businesses.
Taikang Bybo Dental
Series B in 2012
Taikang Bybo Medical Group is a prominent national dental medical group in China, specializing in comprehensive oral healthcare services for middle and upper-income demographics. The company is committed to delivering high-quality dental treatments and preventive care tailored to all age groups, aiming to enhance long-term oral health and overall well-being. By pursuing an exceptional customer experience and exploring innovative models in the dental sector, Taikang Bybo seeks to establish itself as the leading high-end dental chain brand in the country.
Galloping Horse
Private Equity Round in 2011
Beijing Galloping Horse Film & TV Production Co., Ltd. is a prominent company engaged in the production and distribution of films, television series, and advertising solutions. Founded in 2003 and based in Beijing, China, the company has established a strategic partnership with Digital Domain Media Group. Galloping Horse specializes in creating content that caters to the elite class in China, providing them with entertainment options for social gatherings. Through its comprehensive advertising and production services, the company plays a significant role in the Chinese entertainment industry.
Green Leader
Convertible Note in 2010
Green Leader Holdings Group Ltd is a mineral exploration and development company primarily focused on investments in the mining sector, with a significant presence in Mongolia. The company operates through four main segments: Mining Operations, which involves geological surveys, exploration, and the development and sale of coking coal; Systems Integration Services and Software Solutions, offering IT products, systems integration, technology services, and software development; Cassava Starch Operations, which focuses on the cultivation and processing of cassava starch for commercial sale; and Coal Operations, which specializes in coal trading. Through these diverse segments, Green Leader aims to leverage opportunities in both the mining and technology industries.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.